Skip to Content

Baxter Healthcare/Fannin Compounding

M/15/026

Completed

Transaction details

The proposed acquisition by Baxter Healthcare Limited of certain assets relating to the medical compounding business of Fannin Limited has been cleared by the Competition and Consumer Protection Commission.
Case details
  • Notification date:8 June 2015
  • Publication date:8 June 2015
  • Economic sector:Manufacturing - C
  • Economic sub-sector:Manufacture of pharmaceuticals - C.21
  • Request for information:Yes
  • Outcome:Cleared
Documents
M.15.026 Phase 1 Merger AnnouncementPDF | 214 KB
M.15.026 Phase 1 DeterminationPDF | 136 KB
M.15.026 Phase 2 Merger AnnouncementPDF | 431 KB
M.15.026 Phase 2 DeterminationPDF | 723 KB
Timetable

Phase One

  • Tuesday, 9 June, 2015 Notification received
  • Monday, 22 June, 2015 Third party submission deadline
  • Friday, 17 July, 2015 Further information required
  • Friday, 24 July, 2015 Further information received
  • Thursday, 3 September, 2015 Determination issued

Phase Two

  • Thursday, 3 September, 2015 Phase 2 begins
  • Thursday, 3 September, 2015 Third party submission deadline
  • Wednesday, 21 October, 2015 Phase 2 determination issued
Parties Involved

Baxter Healthcare Limited

Baxter Healthcare is a global healthcare company primarily active in the medical device, pharmaceutical and biotechnology sectors.

 

Fannin Limited

Fannin is a provider of medical devices, medicines, diagnostic products and related services in Ireland.
Contacts

mergers@ccpc.ie

View all mergers

Sign up for the latest news from CCPC